The Biosynthesis of DMT
Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.
Articles - Page 21
Psilocybin to Treat Anxiety and Depression in Cancer Patients
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
Beyond Ayahuasca: Therapeutic Effects of N,N-Dimethyltryptamine (DMT)
Researchers are uncovering reasons to think there’s more to DMT than just hallucinations.
What is Allosteric Modulation?
This phenomenon plays an important role in psychedelic drug research and development.
What is Salvia divinorum?
The primary active compound in this plant is more potent than LSD.
Solved: The Crystal Structure of N-Methyl-N-Propyltryptamine (MPT)
This structural analog of DMT is an understudied compound presenting new options for psychedelic drug development.
Psychedelics May Relieve Chronic Pain Via Changes in Brain Neuroplasticity
Using psychedelics to treat chronic pain is understudied yet full of potential.
MDMA for PTSD Showing Promising Outcomes for Patients in MAPS Phase 3 Trials
“In the pharmaceutical drug development community, this is what you dream about.”
Psychedelics and Endurance Sports: Increased Energy and Reduced Fatigue?
One mechanism of action may be similar to taking amphetamines.